NO930738D0 - Nye cyklosporinger, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav - Google Patents

Nye cyklosporinger, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav

Info

Publication number
NO930738D0
NO930738D0 NO930738A NO930738A NO930738D0 NO 930738 D0 NO930738 D0 NO 930738D0 NO 930738 A NO930738 A NO 930738A NO 930738 A NO930738 A NO 930738A NO 930738 D0 NO930738 D0 NO 930738D0
Authority
NO
Norway
Prior art keywords
procedures
preparation
pharmaceutical preparations
new cycle
cycle tracks
Prior art date
Application number
NO930738A
Other languages
English (en)
Other versions
NO930738L (no
NO310685B1 (no
Inventor
Johann J Boelsterli
Marcel K Eberle
Reto Naef
Trevor G Payne
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO930738D0 publication Critical patent/NO930738D0/no
Publication of NO930738L publication Critical patent/NO930738L/no
Publication of NO310685B1 publication Critical patent/NO310685B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Gasification And Melting Of Waste (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19930738A 1992-03-02 1993-03-01 Nye cyklosporiner, fremgangsmåte for deres fremstilling, anvendelsen herav for fremstilling av medikamenter samtfarmasöytiske preparater inneholdende disse NO310685B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929204466A GB9204466D0 (en) 1992-03-02 1992-03-02 Improvements in or relating to organic compounds

Publications (3)

Publication Number Publication Date
NO930738D0 true NO930738D0 (no) 1993-03-01
NO930738L NO930738L (no) 1993-09-03
NO310685B1 NO310685B1 (no) 2001-08-13

Family

ID=10711333

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19930738A NO310685B1 (no) 1992-03-02 1993-03-01 Nye cyklosporiner, fremgangsmåte for deres fremstilling, anvendelsen herav for fremstilling av medikamenter samtfarmasöytiske preparater inneholdende disse

Country Status (26)

Country Link
US (1) US5643870A (no)
EP (1) EP0577544B1 (no)
JP (1) JP3382656B2 (no)
KR (1) KR100256988B1 (no)
CN (1) CN1037104C (no)
AT (1) ATE146484T1 (no)
AU (1) AU667072B2 (no)
CA (1) CA2090634C (no)
CZ (1) CZ285421B6 (no)
DE (1) DE69306670T2 (no)
DK (1) DK0577544T3 (no)
ES (1) ES2096262T3 (no)
FI (1) FI111729B (no)
GB (1) GB9204466D0 (no)
GR (1) GR3022539T3 (no)
HU (1) HU214028B (no)
IL (1) IL104891A (no)
MX (1) MX9301129A (no)
MY (1) MY106921A (no)
NO (1) NO310685B1 (no)
NZ (1) NZ247031A (no)
PL (1) PL174816B1 (no)
RU (1) RU2131883C1 (no)
SK (1) SK279529B6 (no)
TW (1) TW264472B (no)
ZA (1) ZA931491B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639852A (en) * 1994-09-01 1997-06-17 Wisconsin Alumni Research Foundation Immunostimulatory agents
CN1130373C (zh) * 1996-09-13 2003-12-10 诺瓦蒂斯有限公司 [3'－脱氧－3'－氧代－MeBmt]'环孢菌素制备方法
US6517860B1 (en) 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
JP4261049B2 (ja) 1997-10-08 2009-04-30 アイソテクニカ インコーポレイテッド 重水素化シクロスポリンアナログおよび免疫調節剤としてのそれらの使用
US6784156B2 (en) * 2001-03-05 2004-08-31 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of respiratory diseases
US20030087813A1 (en) * 2001-10-12 2003-05-08 Or Yat Sun Cyclosporin analogs for the treatment of lung diseases
US6809077B2 (en) * 2001-10-12 2004-10-26 Enanta Pharmaceuticals, Inc. Cyclosporin analogs for the treatment of autoimmune diseases
PL210795B1 (pl) 2001-10-19 2012-03-30 Isotechnika Inc Sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (E), sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (Z), sposób stereoselektywnej syntezy izomeru (E) ISATX247, sposób stereoselektywnej syntezy izomeru (Z) ISATX247 i sposób wytwarzania mieszaniny izomerów ISATX247
US7012065B2 (en) 2003-02-07 2006-03-14 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of immune disorders
AU2004222306A1 (en) * 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
US20040266669A1 (en) * 2003-06-20 2004-12-30 Wu Frank X. H. Cyclosporin derivatives for the treatment of immune disorders
JP2006014722A (ja) * 2004-06-02 2006-01-19 Keio Gijuku 遺伝子マーカー及びその利用
US7511013B2 (en) * 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
EP1809656A4 (en) * 2004-09-29 2009-03-25 Amr Technology Inc CYCLOSPORINAL KINANALOGA AND ITS PHARMACEUTICAL APPLICATIONS
US7361636B2 (en) * 2004-10-06 2008-04-22 Amr Technology, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
DE602005010607D1 (de) * 2004-11-22 2008-12-04 Astellas Pharma Inc Zyklosporinanalog
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
AU2008310956B2 (en) * 2007-10-08 2014-08-07 Aurinia Pharmaceuticals Inc. Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
CN102164948A (zh) * 2008-07-30 2011-08-24 伊索技术制药公司 非免疫抑制的环孢菌素类似分子
CN102458370A (zh) 2009-06-09 2012-05-16 卢克斯生物科技公司 用于眼科用途的表面药物递送***
US20130267460A1 (en) * 2010-09-16 2013-10-10 The Johns Hopkins University Methods of Inhibiting Alphavirus Replication and Treating Alphavirus Infection
DK2651965T3 (en) 2010-12-15 2019-02-18 Contravir Pharmaceuticals Inc CYCLOSPORIN ANALOGUAL MODULES MODIFIED BY AMINO ACID 1 AND 3
CN105076117B (zh) * 2014-10-31 2017-08-25 北京林业大学 一种种子抗老化剂及其制备方法
KR20170000243U (ko) 2015-07-09 2017-01-18 (주)하나피앤씨 배관연결용 플랜지 기구
US9981041B2 (en) * 2016-08-23 2018-05-29 Ira Jason Salzman Ophthalmic lubricating spray
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
EP0194972B1 (en) * 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4764503A (en) * 1986-11-19 1988-08-16 Sandoz Ltd. Novel cyclosporins
EP0283801A3 (en) * 1987-03-27 1990-05-30 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
ATE95193T1 (de) * 1987-06-17 1993-10-15 Sandoz Ag Cyclosporine und deren benutzung als arzneimittel.
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
JPH04502328A (ja) * 1988-12-05 1992-04-23 ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク シクロスポリンａの新規誘導体、それに対する抗体及びその使用
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
GB8916901D0 (en) * 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
FI111730B (fi) * 1990-11-02 2003-09-15 Novartis Ag Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi

Also Published As

Publication number Publication date
CZ30393A3 (en) 1994-02-16
GR3022539T3 (en) 1997-05-31
MX9301129A (es) 1994-07-29
AU3387293A (en) 1993-09-09
FI930912A0 (fi) 1993-03-01
JP3382656B2 (ja) 2003-03-04
SK14093A3 (en) 1993-10-06
MY106921A (en) 1995-08-30
DE69306670D1 (de) 1997-01-30
CA2090634C (en) 2005-12-13
ATE146484T1 (de) 1997-01-15
CN1037104C (zh) 1998-01-21
PL297902A1 (en) 1993-09-06
ZA931491B (en) 1994-09-02
US5643870A (en) 1997-07-01
NO930738L (no) 1993-09-03
DE69306670T2 (de) 1997-07-03
JPH07252296A (ja) 1995-10-03
HU214028B (en) 1997-12-29
PL174816B1 (pl) 1998-09-30
CN1076453A (zh) 1993-09-22
HUT64567A (en) 1994-01-28
SK279529B6 (sk) 1998-12-02
CA2090634A1 (en) 1993-09-03
EP0577544A1 (en) 1994-01-05
IL104891A (en) 1997-04-15
RU2131883C1 (ru) 1999-06-20
DK0577544T3 (da) 1997-04-01
IL104891A0 (en) 1993-07-08
NZ247031A (en) 1995-05-26
GB9204466D0 (en) 1992-04-15
CZ285421B6 (cs) 1999-08-11
NO310685B1 (no) 2001-08-13
TW264472B (no) 1995-12-01
FI930912A (fi) 1993-09-03
KR100256988B1 (ko) 2000-05-15
ES2096262T3 (es) 1997-03-01
HU9300418D0 (en) 1993-05-28
KR930019692A (ko) 1993-10-18
EP0577544B1 (en) 1996-12-18
AU667072B2 (en) 1996-03-07
FI111729B (fi) 2003-09-15

Similar Documents

Publication Publication Date Title
NO930738L (no) Nye cyklosporinger, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav
MX9803753A (es) Acidos alfa-iminohidroxamicos y -carboxilicos n-sustituidos ciclicos y heterociclicos.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
GEP20002300B (en) Purified Forms of Dnase, Method for Its Production, Pharmaceutical Composition and Use Thereof
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
TR199900770T2 (xx) Nazal poliplerin tedavisinde bir H+, K+-ATPase'�n kullan�lmas�.
CA2163197A1 (en) Tri(platinum) complexes
SE9402880D0 (sv) New peptide derivatives
DK0743940T3 (da) Nye forbindelser med analgetisk og local-anæstetisk virkning
NO921906D0 (no) Nye 2-amino-5-cyano-1,4-dihydropyridiner, deres fremstilling og anvendelse i legemidler
HUT42102A (en) Process for preparing peptides with pharmaceutical activity
NO995838L (no) Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme
NO982863L (no) Nye forbindelser med analgetisk effekt
FR2674434B1 (fr) Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation.
GR3001862T3 (en) Pharmaceutical preparation for tinea pedis
DK0613375T3 (da) Farmaceutiske lysinholdige polypeptidpræparater og anvendelse deraf
ZA942686B (en) Active compound from a sponge
ATE178800T1 (de) Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees